Pharmacists may earn 1.00 CPE Credit (0.10 CEUs) by completing this course on the American Society of Health-System Pharmacists (ASHP) website. Please click here to go to the course (you will leave the myCME website, and free registration on the ASHP website is required). Your certificate will save on ASHP.org and will not be included in your myCME CME History.
This continuing medical education activity is provided by the American Society of Health-System Pharmacists (ASHP).
Supported by an educational grant from Merck
Unintended pregnancy is a major public health problem in the United States. Unintended pregnancy usually is the result of failure to use contraception or inconsistent or incorrect use of effective contraceptive methods. Long-acting reversible contraceptives (LARCs) are the most effective and consistently used contraceptives. This two-part series addresses guidelines that encourage the use of LARCs because of the high efficacy, safety, and ease of use.
This activity was planned to meet the educational needs of physicians, nurse practitioners, physician assistants, and pharmacists caring for patients interested in contraceptive options.
At the conclusion of this application-based educational activity, participants should be able to:
Compare and contrast properties of available LARCs
Using patient scenarios, choose the most appropriate LARC option by considering patient-specific factors
Discuss ways to assist patients in navigating the variations in institutional access to LARCs
Conflict Of Interest Disclosure Policy
In accordance with ACCME and ACPE Standards for Commercial Support, ASHP policy requires that all faculty, planners, reviewers, staff, and others in a position to control the content of this presentation disclose their financial relationships.
Liza W. Claus, PharmD, BCACP Assistant Professor, Department of Clinical Pharmacy University of Colorado Skaggs School of Pharmacy & Pharmaceutical Sciences Aurora, CO
The planners and managers reported no financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity.
AMA PRA Category 1 Credit(s)TM
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Society of Health-System Pharmacists designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
In order to receive credit, participants must complete the pre-assessment questions, post-assessment questions, and program evaluation. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.
For information about the accreditation of this program, please contact firstname.lastname@example.org.